1. De Santis, V, Nencini, C, Tritapepe, L. Comparison of dopamine and norepinephrine in shock. N Engl J Med. 2010;362:2329; author rely 2330-2329; author rely 2331.
Google Scholar | Medline2. Cuffe, MS, Califf, RM, Adams, KF, et al. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. JAMA. 2002;287:1541-1547.
Google Scholar | Crossref | Medline | ISI3. Felker, GM, Benza, RL, Chandler, AB, et al. Heart failure etiology and response to milrinone in decompensated heart failure: results from the OPTIME-CHF study. J Am Coll Cardiol. 2003;41:997-1003.
Google Scholar | Crossref | Medline | ISI4. Verma, S, Bassily, E, Leighton, S, et al. Renal function and outcomes with use of left ventricular assist device implantation and inotropes in end-stage heart failure: a retrospective single center study. J Clin Med Res. 2017;9:596-604.
Google Scholar | Crossref | Medline5. Nanas, JN, Tsagalou, EP, Kanakakis, J, et al. Long-term intermittent dobutamine infusion, combined with oral amiodarone for end-stage heart failure: a randomized double-blind study. Chest. 2004;125:1198-1204.
Google Scholar | Crossref | Medline6. O’Connor, CM, Gattis, WA, Uretsky, BF, et al. Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: insights from the Flolan International randomized survival trial (FIRST). Am Heart J. 1999;138:78-86.
Google Scholar | Crossref | Medline | ISI7. Yancy, CW, Jessup, M, Bozkurt, B, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2013;128:e240-e327.
Google Scholar8. Elis, A, Bental, T, Kimchi, O, Ravid, M, Lishner, M. Intermittent dobutamine treatment in patients with chronic refractory congestive heart failure: a randomized, double-blind, placebo-controlled study. Clin Pharmacol Ther. 1998;63:682-685.
Google Scholar | Crossref | Medline9. Elkayam, U, Tasissa, G, Binanay, C, et al. Use and impact of inotropes and vasodilator therapy in hospitalized patients with severe heart failure. Am Heart J. 2007;153:98-104.
Google Scholar | Crossref | Medline | ISI10. van den Akker, JPC, Bakker, J, Groeneveld, ABJ, den Uil, CA. Risk indicators for acute kidney injury in cardiogenic shock. J Crit Care. 2019;50:11-16.
Google Scholar | Crossref | Medline11. Na, SJ, Chung, CR, Cho, YH, et al. Vasoactive inotropic score as a predictor of mortality in adult patients with cardiogenic shock: medical therapy versus ECMO. Rev Esp Cardiol. 2019;72:40-47.
Google Scholar | Crossref | Medline12. Baran, DA, Grines, CL, Bailey, S, et al. SCAI clinical expert consensus statement on the classification of cardiogenic shock. Catheter Cardiovasc Interv. 2019;94:29-37.
Google Scholar | Medline13. Harjola, V-P, Lassus, J, Sionis, A, et al. Clinical picture and risk prediction of short-term mortality in cardiogenic shock. Eur J Heart Fail. 2015;17:501-509.
Google Scholar | Crossref | Medline | ISI14. Jentzer, JC, van Diepen, S, Barsness, GW, et al. Cardiogenic shock classification to predict mortality in the cardiac intensive care unit. J Am Coll Cardiol. 2019;74:2117-2128.
Google Scholar | Crossref | Medline15. Abraham, WT, Adams, KF, Fonarow, CG. In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the acute decompensated heart failure national registry (ADHERE). ACC Curr J Rev. 2005;14:26-64.
Google Scholar | Crossref16. Follath, F, Yilmaz, MB, Delgado, JF, et al. Clinical presentation, management and outcomes in the acute heart failure global survey of standard treatment (ALARM-HF). Intensive Care Med. 2011;37:619-626.
Google Scholar | Crossref | Medline | ISI17. Fonarow, GC, Corday, E; ADHERE Scientific Advisory Committee . Overview of acutely decompensated congestive heart failure (ADHF): a report from the ADHERE registry. Heart Fail Rev. 2004;9:179-185.
Google Scholar | Crossref | Medline | ISI18. Mebazaa, A, Parissis, J, Porcher, R, et al. Short-term survival by treatment among patients hospitalized with acute heart failure: the global ALARM-HF registry using propensity scoring methods. Intensive Care Med. 2011;37:290-301.
Google Scholar | Crossref | Medline | ISI19. Den Uil, CA, Van Mieghem, NM, B Bastos, M, et al. Primary intra-aortic balloon support versus inotropes for decompensated heart failure and low output: a randomised trial. EuroIntervention. 2019;15:586-593.
Google Scholar | Crossref | Medline